CD45, CD148, and Lyp/Pep: Critical phosphatases regulating Src family kinase signaling networks in immune cells

Immunological Reviews

Volumn 228, Issue 1, 2009, Pages 288-311

  Hermiston, Michelle L ^a   Zikherman, Julie ^a   Zhu, Jing W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; CD148; CD45; Pep Lyp; Phosphatase; PTPN22

Indexed keywords

CD45 ANTIGEN; PHOSPHATASE; PROTEIN TYROSINE KINASE;

ANTIGEN FUNCTION; ANTIGEN STRUCTURE; ARTICLE; B LYMPHOCYTE; ENZYME ACTIVITY; ENZYME REGULATION; HEMATOPOIETIC CELL; IMMUNOCOMPETENT CELL; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD45; BLOOD CELLS; HUMANS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 12; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; SIGNAL TRANSDUCTION;

EID: 61849136595     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00752.x     Document Type: Article

References (175)

1. Acuto O, Bartolo VD, Michel F. Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat Rev Immunol 2008 8 : 699 712.
2. Hermiston ML, Xu Z, Majeti R, Weiss A. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J Clin Invest 2002 109 : 9 14.
3. Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC, Mustelin T. Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol 2008 26 : 29 55.
4. Lowell CA. Src-family kinases: rheostats of immune cell signaling. Mol Immunol 2004 41 : 631 643.
5. Palacios EH, Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 2004 23 : 7990 8000.
6. Young MA, Gonfloni S, Superti-Furga G, Roux B, Kuriyan J. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell 2001 105 : 115 126.
7. Nika K, Tautz L, Arimura Y, Vang T, Williams S, Mustelin T. A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling. J Biol Chem 2007 282 : 36000 36009.
8. Sieh M, Bolen JB, Weiss A. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J 1993 12 : 315 322.
9. lck. J Exp Med 1990 172 : 347 350.
10. Thomas ML, Brown EJ. Positive and negative regulation of Src-family membrane kinases by CD45. Immunol Today 1999 20 : 406 411.
11. Falahati R, Leitenberg D. Changes in the role of the CD45 protein tyrosine phosphatase in regulating Lck tyrosine phosphorylation during thymic development. J Immunol 2007 178 : 2056 2064.
12. Thomas ML, Lefrancois L. Differential expression of the leucocyte-common antigen family. Immunol Today 1988 9 : 320 326.
13. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003 21 : 107 137.
14. Holmes N. CD45: all is not yet crystal clear. Immunol 2006 117 : 145 155.
15. Mee PJ, Turner M, Basson MA, Costello PS, Zamoyska R, Tybulewicz VL. Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice. Eur J Immunol 1999 29 : 2923 2933.
16. Byth KF, et al. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp Med 1996 183 : 1707 1718.
17. Kishihara K, et al. Normal B lymphocyte development but impaired T cell maturation in CD45-Exon6 protein tyrosine phosphatase-deficient mice. Cell 1993 74 : 143 156.
18. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 2001 166 : 1308 1313.
19. Kung C, et al. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000 6 : 343 345.
20. Tchilian EZ, Beverley PC. Altered CD45 expression and disease. Trends Immunol 2006 27 : 146 153.
21. Earl LA, Baum LG. CD45 Glycosylation controls T-cell life and death. Immunol Cell Biol 2008 86 : 608 615.
22. Hernandez JD, Klein J, Van Dyken SJ, Marth JD, Baum LG. T-cell activation results in microheterogeneous changes in glycosylation of CD45. Int Immunol 2007 19 : 847 856.
23. van Vliet SJ, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol 2006 7 : 1200 1208.
24. Chen IJ, Chen HL, Demetriou M. Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling. J Biol Chem 2007 282 : 35361 35372.
25. Nam HJ, Poy F, Saito H, Frederick CA. Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45. J Exp Med 2005 201 : 441 452.
26. Desai DM, Sap J, Silvennoinen O, Schlessinger J, Weiss A. The catalytic activity of the CD45 membrane-proximal phosphatase domain is required for TCR signaling and regulation. EMBO J 1994 13 : 4002 4010.
27. Wang Y, Guo W, Liang L, Esselman WJ. Phosphorylation of CD45 by casein kinase 2. Modulation of activity and mutational analysis. J Biol Chem 1999 274 : 7454 7461.
28. Greer SF, Justement LB. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1. J Immunol 1999 162 : 5278 5286.
29. Wang Y, et al. Visualizing the mechanical activation of Src. Nature 2005 434 : 1040 1045.
30. Bilwes AM, den Hertog J, Hunter T, Noel JP. Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization. Nature 1996 382 : 555 559.
31. Majeti R, Bilwes AM, Noel JP, Hunter T, Weiss A. Ligand-induced dimerization regulates receptor protein tyrosine phosphatase function via an inhibitory wedge. Science 1998 279 : 88 91.
32. Majeti R, et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 2000 103 : 1059 1070.
33. Hermiston ML, Tan AL, Gupta VA, Majeti R, Weiss A. The juxtamembrane wedge negatively regulates CD45 function in B cells. Immunity 2005 23 : 635 647.
34. McNeill L, Cassady RL, Sarkardei S, Cooper JC, Morgan G, Alexander DR. CD45 isoforms in T cell signalling and development. Immunol Lett 2004 92 : 125 134.
35. Lynch KW, Weiss A. A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates PKC and Ras. Mol Cell Biol 2000 20 : 70 80.
36. Lynch KW. Consequences of regulated pre-mRNA splicing in the immune system. Nat Rev Immunol 2004 4 : 931 940.
37. Melton AA, Jackson J, Wang J, Lynch KW. Combinatorial control of signal-induced exon repression by hnRNP L and PSF. Mol Cell Biol 2007 27 : 6972 6984.
38. Oberdoerffer S, Moita LF, Neems D, Freitas RP, Hacohen N, Rao A. Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL. Science 2008 321 : 686 691.
39. Topp JD, Jackson J, Melton AA, Lynch KW. A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4. RNA 2008 14 : 2038 2049.
40. Furukawa T, Itoh M, Krueger NX, Streuli M, Saito H. Specific interaction of the CD45-protein tyrosine phosphatase with tyrosine phosphorylated CD3 ζ chain. Proc Natl Acad Sci USA 1994 91 : 10928 10932.
41. Wu L, Fu J, Shen SH. SKAP55 coupled with CD45 positively regulates T-cell receptor-mediated gene transcription. Mol Cell Biol 2002 22 : 2673 2686.
42. Irie-Sasaki J, et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 2001 409 : 349 354.
43. Davidson D, Bakinowski M, Thomas ML, Horejsi V, Veillette A. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol Cell Biol 2003 23 : 2017 2028.
44. Zamoyska R. Why is there so much CD45 on T cells? Immunity 2007 27 : 421 423.
45. Huntington ND, Tarlinton DM. CD45: direct and indirect government of immune regulation. Immunol Lett 2004 94 : 167 174.
46. Alexander DR. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin Immunol 2000 12 : 349 359.
47. Pingel S, Baker M, Turner M, Holmes N, Alexander DR. The CD45 tyrosine phosphatase regulates CD3-induced signal transduction and T cell development in recombinase-deficient mice: restoration of pre-TCR function by active p56(lck). Eur J Immunol 1999 29 : 2376 2384.
48. Ostergaard HL, et al. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci USA 1989 86 : 8959 8963.
49. Mustelin T, et al. Regulation of the p59fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur J Immunol 1992 22 : 1173 1178.
50. Stone JD, Howlett S, Byth KF, Holmes N, Alexander DR. T-cell antigen receptor signal transduction in CD45-/- thymocytes. Biochem Soc Trans 1997 25 : 302S.
51. lck Y505F mutation in CD45-deficient mice rescues thymocyte development. Mol Cell Biol 1999 19 : 4200 4208.
52. van Oers NSC, Lowin-Kropf B, Finlay D, Connolly K, Weiss A. αβ T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 1996 5 : 429 436.
53. Roach T, et al. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol 1997 7 : 408 417.
54. Shenoi H, Seavitt J, Zheleznyak A, Thomas ML, Brown EJ. Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45. J Immunol 1999 162 : 7120 7127.
55. Ashwell JD, D'Oro U. CD45 and Src-family kinases: and now for something completely different. Immunol Today 1999 20 : 412 416.
56. Baker M, et al. Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutatnt lck mice. EMBO J 2000 19 : 4644 4654.
57. McNeill L, et al. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses. Immunity 2007 27 : 425 437.
58. Wallace VA, et al. Alterations in the level of CD45 surface expression affect the outcome of thymic selection. J Immunol 1997 158 : 3205 3214.
59. Hermiston ML, et al. Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses. Prod Natl Acad Sci USA 2009 doi:.
60. Bosma GC, Custer RP, Bosma MJ. Severe combined immunodeficiency in the mouse. Nature 1983 301 : 527 530.
61. Zamoyska R, Basson A, Filby A, Legname G, Lovatt M, Seddon B. The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation. Immunol Rev 2003 191 : 107 118.
62. Maksumova L, Le HT, Muratkhodjaev F, Davidson D, Veillette A, Pallen CJ. Protein tyrosine phosphatase alpha regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts. J Immunol 2005 175 : 7947 7956.
63. Loder F, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 1999 190 : 75 89.
64. Fleming HE, Milne CD, Paige CJ. CD45-deficient mice accumulate Pro-B cells both in vivo and in vitro. J Immunol 2004 173 : 2542 2551.
65. Benatar T, Carsetti R, Furlonger C, Kamalia N, Mak T, Paige CJ. Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J Exp Med 1996 183 : 329 334.
66. Saijo K, et al. Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nat Immunol 2003 4 : 274 279.
67. Huntington ND, et al. CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers. Nat Immunol 2006 7 : 190 198.
68. Zhu JW, Brdicka T, Katsumoto TR, Lin J, Weiss A. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity 2008 28 : 183 196.
69. Kong YY, Kishihara K, Sumichika H, Nakamura T, Kaneko M, Nomoto K. Differential requirements of CD45 for lymphocyte development and function. Eur J Immunol 1995 25 : 3431 3436.
70. Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 1996 381 : 325 328.
71. Cyster JG, Goodnow CC. Protein tyrosine phopshatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995 2 : 13 24.
72. Shrivastava P, Katagiri T, Ogimoto M, Mizuno K, Yakura H. Dynamic regulation of Src-family kinases by CD45 in B cells. Blood 2004 103 : 1425 1432.
73. Katagiri T, et al. CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells. J Immunol 1999 163 : 1321 1326.
74. Katagiri T, Ogimoto M, Hasegawa K, Mizuno K, Yakura H. Selective regulation of Lyn tyrosine kinase by CD45 in immature B cells. J Biol Chem 1995 270 : 27987 27990.
75. Chan VW, Lowell CA, DeFranco AL. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr Biol 1998 8 : 545 553.
76. Hibbs ML, et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 1995 83 : 301 311.
77. Hibbs ML, et al. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med 2002 196 : 1593 1604.
78. Gauld SB, Dal Porto JM, Cambier JC. B cell antigen receptor signaling: roles in cell development and disease. Science 2002 296 : 1641 1642.
79. Yamada H, Kishihara K, Kong YY, Nomoto K. Enhanced generation of NK cells with intact cytotoxic function in CD45 exon 6-deficient mice. J Immunol 1996 157 : 1523 1528.
80. Hesslein DG, Takaki R, Hermiston ML, Weiss A, Lanier LL. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc Natl Acad Sci USA 2006 103 : 7012 7017.
81. Huntington ND, Xu Y, Nutt SL, Tarlinton DM. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells. J Exp Med 2005 201 : 1421 1433.
82. Mason LH, Willette-Brown J, Taylor LS, McVicar DW. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J Immunol 2006 176 : 6615 6623.
83. Berger SA, Mak TW, Paige CJ. Leukocyte common antigen (CD45) is required for immunoglobulin E-mediated degranulation of mast cells. J Exp Med 1994 180 : 471 476.
84. Cross JL, Kott K, Miletic T, Johnson P. CD45 regulates TLR-induced proinflammatory cytokine and IFN-beta secretion in dendritic cells. J Immunol 2008 180 : 8020 8029.
85. Piercy J, Petrova S, Tchilian EZ, Beverley PC. CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells. Immunol 2006 118 : 250 256.
86. Montoya M, et al. CD45 is required for type I IFN production by dendritic cells. Eur J Immunol 2006 36 : 2150 2158.
87. Zhang H, Meng F, Chu CL, Takai T, Lowell CA. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 2005 22 : 235 246.
88. Hamerman JA, Tchao NK, Lowell CA, Lanier LL. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 2005 6 : 579 586.
89. Fortin M, et al. Apoptosis mediated through CD45 is independent of its phosphatase activity and association with leukocyte phosphatase-associated phosphoprotein. J Immunol 2002 168 : 6084 6089.
90. Anand AR, Ganju RK. HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. J Biol Chem 2006 281 : 12289 12299.
91. Liu Z, Dawes R, Petrova S, Beverley PC, Tchilian EZ. CD45 regulates apoptosis in peripheral T lymphocytes. Int Immunol 2006 18 : 959 966.
92. Desharnais P, Dupere-Minier G, Hamelin C, Devine P, Bernier J. Involvement of CD45 in DNA fragmentation in apoptosis induced by mitochondrial perturbing agents. Apoptosis 2008 13 : 197 212.
93. Klaus SJ, Sidorenko SP, Clark EA. CD45 ligation induces programmed cell death in T and B lymphocytes. J Immunol 1996 156 : 2743 2753.
94. Bijian K, Zhang L, Shen SH. Collagen-mediated survival signaling is modulated by CD45 in Jurkat T cells. Mol Immunol 2007 44 : 3682 3690.
95. Gupta VA, Hermiston ML, Cassafer G, Daikh DI, Weiss A. B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency. J Exp Med 2008 12 : 2755 2761.
96. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2-6 sialyltransferase, CD75, on B cells. Cell 1991 66 : 1133 1144.
97. Walzel H, Schulz U, Neels P, Brock J. Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. Immunol Lett 1999 67 : 193 202.
98. Baldwin TA, Gogela-Spehar M, Ostergaard HL. Specific isoforms of the resident endoplasmic reticulum protein glucosidase II associate with the CD45 protein-tyrosine phosphatase via a lectin-like interaction. J Biol Chem 2000 275 : 32071 32076.
99. Felberg J, Johnson P. Characterization of recombinant CD45 cytoplasmic domain proteins. Evidence for intramolecular and intermolecular interactions. J Biol Chem 1998 273 : 17839 17845.
100. Takeda A, Wu JJ, Maizel AL. Evidence for monomeric and dimeric forms of CD45 associated with a 30-kDa phosphorylated protein. J Biol Chem 1992 267 : 16651 16659.
101. Dornan S, et al. Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. J Biol Chem 2002 277 : 1912 1918.
102. Xu Z, Weiss A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat Immunol 2002 3 : 764 771.
103. Desai DM, Sap J, Schlessinger J, Weiss A. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase. Cell 1993 73 : 541 554.
104. van der Wijk T, Blanchetot C, Overvoorde J, den Hertog J. Redox-regulated rotational coupling of receptor protein-tyrosine phosphatase alpha dimers. J Biol Chem 2003 278 : 13968 13974.
105. Dustin ML. Hunter to gatherer and back: immunological synapses and kinapses as variations on the theme of amoeboid locomotion. Annu Rev Cell Dev Biol 2008 24 : 577 596.
106. Douglass AD, Vale RD. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 2005 121 : 937 950.
107. Choudhuri K, van der Merwe PA. Molecular mechanisms involved in T cell receptor triggering. Semin Immunol 2007 19 : 255 261.
108. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 2006 25 : 117 127.
109. Yokosuka T, et al. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol 2005 6 : 1253 1262.
110. Campi G, Varma R, Dustin ML. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J Exp Med 2005 202 : 1031 1036.
111. He X, Woodford-Thomas TA, Johnson KG, Shah DD, Thomas ML. Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling. Eur J Immunol 2002 32 : 2578 2587.
112. Su MW, Yu CL, Burakoff SJ, Jin YJ. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation. J Immunol 2001 166 : 3975 3982.
113. Hailman E, Burack WR, Shaw AS, Dustin ML, Allen PM. Immature CD4(+)CD8(+) thymocytes form a multifocal immunological synapse with sustained tyrosine phosphorylation. Immunity 2002 16 : 839 848.
114. Thomas M. The leukocyte common antigen family. Annu Rev Immunol 1989 7 : 339 370.
115. Irles C, Symons A, Michel F, Bakker TR, van der Merwe PA, Acuto O. CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Nat Immunol 2003 4 : 189 197.
116. Pradhan D, Morrow J. The spectrin-ankyrin skeleton controls CD45 surface display and interleukin-2 production. Immunity 2002 17 : 303 315.
117. Hailman E, Allen PM. Inefficient cell spreading and cytoskeletal polarization by CD4+CD8+ thymocytes: regulation by the thymic environment. J Immunol 2005 175 : 4847 4857.
118. Schraven B, et al. LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J Biol Chem 1994 269 : 29102 29111.
119. Leitenberg D, Falahati R, Lu DD, Takeda A. CD45-associated protein promotes the response of primary CD4 T cells to low-potency T-cell receptor (TCR) stimulation and facilitates CD45 association with CD3/TCR and lck. Immunol 2007 121 : 545 554.
120. Matsuda A, Motoya S, Kimura S, McInnis R, Maizel AL, Takeda A. Disruption of lymphocyte function and signaling in CD45-associated protein-null mice. J Exp Med 1998 187 : 1863 1870.
121. Ding I, et al. Biochemical and functional analysis of mice deficient in expression of the CD45-associated phosphoprotein LPAP. Eur J Immunol 1999 29 : 3956 3961.
122. Kung C, et al. CD45-associated protein is not essential for the regulation of antigen receptor-mediated signal transduction. Eur J Immunol 1999 29 : 3951 3955.
123. Stover DR, Charbonneau H, Tonks NK, Walsh KA. Protein-tyrosine- phosphatase CD45 is phosphorylated transiently on tyrosine upon activation of Jurkat T cells. Proc Natl Acad Sci USA 1991 88 : 7704 7707.
124. lck tyrosine kinase and activates the phosphatase. Mol Cell Biol 1994 14 : 1308 1321.
125. Fialkow L, Chan CK, Downey GP. Inhibition of CD45 during neutrophil activation. J Immunol 1997 158 : 5409 5417.
126. Windhagen A, Sonmez D, Hornig-Do HT, Kalinowsky A, Schwinzer R. Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells. Clin Exp Immunol 2007 150 : 509 517.
127. Dawes R, Petrova S, Liu Z, Wraith D, Beverley PC, Tchilian EZ. Combinations of CD45 isoforms are crucial for immune function and disease. J Immunol 2006 176 : 3417 3425.
128. Schraven B. CD148. J Biol Regul Homeost Agents 2000 14 : 220 222.
129. Baker JE, Majeti R, Tangye SG, Weiss A. Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase C gamma1 phosphorylation. Mol Cell Biol 2001 21 : 2393 2403.
130. Borges LG, et al. Cloning and characterization of rat density-enhanced phosphatase-1, a protein tyrosine phosphatase expressed by vascular cells. Circ Res 1996 79 : 570 580.
131. Gaya A, et al. CD148, a new membrane tyrosine phosphatase involved in leukocyte function. Leuk Lymphoma 1999 35 : 237 243.
132. Kuramochi S, Matsuda S, Matsuda Y, Saitoh T, Ohsugi M, Yamamoto T. Molecular cloning and characterization of Byp, a murine receptor-type tyrosine phosphatase similar to human DEP-1. FEBS Lett 1996 378 : 7 14.
133. Lin J, Zhu JW, Baker JE, Weiss A. Regulated expression of the receptor-like tyrosine phosphatase CD148 on hemopoietic cells. J Immunol 2004 173 : 2324 2330.
134. Balavenkatraman KK, et al. DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene 2006 25 : 6319 6324.
135. Keane MM, Lowrey GA, Ettenberg SA, Dayton MA, Lipkowitz S. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res 1996 56 : 4236 4243.
136. Trapasso F, et al. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol 2000 20 : 9236 9246.
137. Trapasso F, et al. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Carcinogenesis 2004 25 : 2107 2114.
138. Autschbach F, et al. Expression of the membrane protein tyrosine phosphatase CD148 in human tissues. Tissue Antigens 1999 54 : 485 498.
139. Tangye SG, Phillips JH, Lanier LL, deVries JE, Aversa G. CD148: a receptor-like protein tyrosine phosphatase involved in the regulation of human T cell activation. J Immunol 1998 161 : 3249 3255.
140. Ruivenkamp C, et al. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene 2003 22 : 3472 3474.
141. Ruivenkamp CA, et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 2002 31 : 295 300.
142. Lunardi C, et al. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 2002 360 : 915 921.
143. Holsinger LJ, Ward K, Duffield B, Zachwieja J, Jallal B. The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn). Oncogene 2002 21 : 7067 7076.
144. Kovalenko M, et al. Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J Biol Chem 2000 275 : 16219 16226.
145. Palka HL, Park M, Tonks NK. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J Biol Chem 2003 278 : 5728 5735.
146. Pera IL, et al. The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene 2005 24 : 3187 3195.
147. Persson C, Engstrom U, Mowbray SL, Ostman A. Primary sequence determinants responsible for site-selective dephosphorylation of the PDGF beta-receptor by the receptor-like protein tyrosine phosphatase DEP-1. FEBS Lett 2002 517 : 27 31.
148. Tsuboi N, et al. The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J 2008 413 : 193 200.
149. Lin J, Weiss A. The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling. J Cell Biol 2003 162 : 673 682.
150. Takahashi T, et al. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol Cell Biol 2003 23 : 1817 1831.
151. Trapasso F, et al. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. DNA Cell Biol 2006 25 : 376 382.
152. Matthews RJ, Bowne DB, Flores E, Thomas ML. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 1992 12 : 2396 2405.
153. Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999 93 : 2013 2024.
154. csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J 1996 15 : 4909 4918.
155. Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999 189 : 111 121.
156. Gjorloff-Wingren A, Saxena M, Williams S, Hammi D, Mustelin T. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol 1999 29 : 3845 3854.
157. Wu J, et al. Identification of substrates of human protein-tyrosine phosphatase PTPN22. J Biol Chem 2006 281 : 11002 11010.
158. Brdicka T, et al. Phosphoprotein associated with glycosphingolipid- enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med 2000 191 : 1591 1604.
159. Kawabuchi M, et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 2000 404 : 999 1003.
160. Davidson D, Cloutier JF, Gregorieff A, Veillette A. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells. J Biol Chem 1997 272 : 23455 23462.
161. Gregorieff A, Cloutier JF, Veillette A. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk). J Biol Chem 1998 273 : 13217 13222.
162. Davidson D, Veillette A. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J 2001 20 : 3414 3426.
163. Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004 303 : 685 689.
164. Yu X, et al. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc Natl Acad Sci USA 2007 104 : 19767 19772.
165. Begovich AB, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004 75 : 330 337.
166. Bottini N, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004 36 : 337 338.
167. Kyogoku C, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004 75 : 504 507.
168. Plenge RM, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007 357 : 1199 1209.
169. Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006 18 : 214 223.
170. Karlson EW, et al. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann Rheum Dis 2008 67 : 358 363.
171. Lefvert AK, Zhao Y, Ramanujam R, Yu S, Pirskanen R, Hammarstrom L. PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis. J Neuroimmunol 2008 197 : 110 113.
172. Gomez LM, Anaya JM, Martin J. Genetic influence of PTPN22 R620W polymorphism in tuberculosis. Hum Immunol 2005 66 : 1242 1247.
173. Vang T, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005 37 : 1317 1319.
174. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007 179 : 4704 4710.
175. Aarnisalo J, et al. Reduced CD4+ T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J Autoimmun 2008 31 : 13 21.